ADAR1 Capital Management, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1940272 AUSTIN, TX

Back to CAPR Full portfolio

Position in CAPR

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$2,754,027

+$1,979,571 QoQ

Shares Held

90,593

+61.4% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Dec 31, 2024

CallValue

$1,311,000

CallShares

95,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ADAR1 Capital Management, LLC holds $1,362,941,740 across 211 Biotechnology names. CAPR ranks #87 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,394,019	$155,224,015
2	PTGX	Protagonist Therapeutics, Inc	994,119	$104,780,142
3	ROIV	Roivant Sciences Ltd.	3,285,906	$91,019,596
4	IMVT	Immunovant, Inc.	2,679,010	$66,546,608
5	TERN	Terns Pharmaceuticals, Inc.	914,699	$48,222,931
6	CYTK	Cytokinetics Inc	632,556	$41,691,765
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,139,331	$41,380,501
8	DNLI	Denali Therapeutics Inc.	1,871,455	$35,931,936

All Filings in CAPR

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,754,027	90,593	+61.4%	Shares	Sole	2026-05-18
2024-12-31	$774,456	56,120	-40.9%	Shares	Sole	2025-02-13
2024-12-31	$1,311,000	95,000	+290.8%	Call	Sole	2025-02-13
2024-09-30	$369,709	24,307	+19.2%	Shares	Sole	2024-11-14
2024-06-30	$97,308	20,400	—	Put	Sole	2024-08-13
No filing history on record for this holder in this stock.